Patents by Inventor Dequan Su

Dequan Su has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12415800
    Abstract: Provided is a preparation method of losartan, which is prepared by reacting a cyano group-containing intermediate represented by formula (I) with an azide reagent in toluene in the presence of a catalyst; wherein, after the reaction is completed, azide ions are removed by means of the following process: adding water to divide the reaction system into three layers, separating the intermediate layer and adding n-butanol to the intermediate layer for dilution, and adding triphenylphosphine to the resulting diluted solution so as to remove residual azide ions from the diluted solution. The preparation method provided by the present invention does not need to use sodium nitrite, thus fundamentally eliminating the formation of genotoxic impurities nitrosamines.
    Type: Grant
    Filed: January 17, 2020
    Date of Patent: September 16, 2025
    Assignee: Zhejiang Tianyu Pharmaceutical Co., Ltd.
    Inventors: Zuwei He, Gang Liu, Dequan Su, Ruiyun Lv, Wei Xiao, Zhen Wang, Guorong Zhu, Yongjun Tu
  • Publication number: 20220388988
    Abstract: Provided is a preparation method of losartan, which is prepared by reacting a cyano group-containing intermediate represented by formula (I) with an azide reagent in toluene in the presence of a catalyst; wherein, after the reaction is completed, azide ions are removed by means of the following process: adding water to divide the reaction system into three layers, separating the intermediate layer and adding n-butanol to the intermediate layer for dilution, and adding triphenylphosphine to the resulting diluted solution so as to remove residual azide ions from the diluted solution. The preparation method provided by the present invention does not need to use sodium nitrite, thus fundamentally eliminating the formation of genotoxic impurities nitrosamines.
    Type: Application
    Filed: January 17, 2020
    Publication date: December 8, 2022
    Applicant: Zhejiang Tianyu Pharmaceutical Co., Ltd.
    Inventors: Zuwei He, Gang Liu, Dequan Su, Ruiyun Lv, Wei Xiao, Zhen Wang, Guorong Zhu, Yongjun Tu